Core Viewpoint - The company has developed a comprehensive management solution for medical reagents, enabling automated and intelligent management throughout the entire process from production to sales [1] Group 1: Business Development - The medical reagent management solution is identified as a new growth point for the company, with ongoing market expansion [1] - The company has established a good partnership with ADIDAS, with its products being utilized in several stores across South China, East China, and Southwest China [1] Group 2: Technology and Innovation - The company has developed a series of RFID technology-based products and solutions specifically for urban subway systems, including high-interference-resistant RFID tags, specialized reading and writing devices, and positioning systems [1] - Projects related to urban rail transit are progressing steadily as planned [1]

（记者 胡玲） 每经AI快讯，有投资者在投资者互动平台提问：第一，请问贵公司产品有无应用于疫情防控工作的技 术？有无开发出具体对应产品？有无销售销量？第二，请问贵公司跟ADIDAS合作的进度如何？除了广 州店还在其他地方有新上远望谷设备吗？第三，请问贵公司有无应用于各大城市地铁的产品？市场开发 进度如何？ 远 望 谷（002161.SZ）11月19日在投资者互动平台表示， 1、公司开发的医疗试剂全流程管理解决方 案，能够实现对试剂从生产、仓储、物流到销售的全流程自动化与智慧化管理。目前，该业务作为新兴 业务增长点，市场正在持续拓展中。 2、公司与ADIDAS合作良好，公司的产品在其华南、华东、西南 的不少门店得到应用。 3、公司针对城市地铁研发了一系列基于 RFID 技术的产品与解决方案，核心产 品涵盖高抗干扰 RFID 标签、专用读写设备以及定位系统等，公司城市轨道交通相关项目正按计划稳步 推进。 ...